4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001780088-26-000006
CHIEF MEDICAL OFFICER sold 14,311 shares at an average $31.92 ($456,835)
- CHIEF MEDICAL OFFICER acquired 1,365 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ticho Barry · CHIEF MEDICAL OFFICER
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-17 | Sale : show line 1 in the form 10b5-1 | −3,577 | $32.74 | $117,109 | 50,071 | D |
| 2026-03-17 | Sale : show line 2 in the form 10b5-1 | −2,587 | $33.38 | $86,342 | 47,484 | D |
| 2026-03-18 | Sale : show line 3 in the form 10b5-1 | −6,100 | $31.28 | $190,831 | 41,384 | D |
| 2026-03-18 | Sale : show line 4 in the form 10b5-1 | −483 | $31.79 | $15,354 | 40,901 | D |
| 2026-03-18 | Sale : show line 5 in the form 10b5-1 | −103 | $32.85 | $3,384 | 40,798 | D |
| 2026-03-19 | Exercise or conversion : show line 6 in the form 10b5-1 | +1,365 | $2.19 | $2,989 | 42,163 | D |
| 2026-03-19 | Sale : show line 7 in the form 10b5-1 | −1,461 | $29.99 | $43,815 | 40,702 | D |
| Open-market sales · 14,311 sh · avg $31.92 · $456,835 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-19 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −1,365 | 83,035 | D |
Loading xslF345X06/form4-03192026_100350.xml…